Valuation : Evotec SE

Market Cap 602M 701M 563M 516M 971M 66.99B 974M 6.67B 2.61B 33.54B 2.63B 2.57B 112B P/E 2026 *
-2.88x
P/E 2027 * -7.86x
Enterprise Value 744M 867M 697M 638M 1.2B 82.89B 1.21B 8.25B 3.23B 41.5B 3.26B 3.19B 138B EV / Sales 2026 *
1.24x
EV / Sales 2027 * 1.06x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day+0.89%
1 week-0.59%
Current month-0.76%
1 month-2.03%
3 months-32.46%
6 months-42.23%
Current year-37.91%
1 week 3.24
Extreme 3.24
3.41
1 month 3.24
Extreme 3.24
3.88
Current year 3.18
Extreme 3.176
6.73
1 year 3.18
Extreme 3.176
7.3
3 years 3.18
Extreme 3.176
23.44
5 years 3.18
Extreme 3.176
45.83
10 years 3.18
Extreme 3.176
45.83
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Date Insider Type Main position Quantity % Market Cap.
1/30/26 A Fiscal year

Chief Technology Officer

6,760 0.0038%
1/30/26 A Tax

Chief Technology Officer

3,653 0.0021%
12/9/25 A Buy

Chairman

20,000 0.0113%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%-0.59%-43.34%-83.52% 695M
+0.10%+1.59%+1.76%+24.32% 50.96B
+2.65%+3.02%+493.29%+567.32% 46.18B
-0.88%-1.16%+20.58%+87.74% 42.73B
+0.33%+5.26%+39.74%+19.80% 43.04B
-2.27%-3.02%+14.22%+51.50% 33.48B
-1.21%+0.54%+30.32%+135.38% 17.28B
-0.36%-3.95% - - 16.43B
+0.25%+3.31%+11.38%+30.68% 14.73B
+0.44%+2.21%+81.06%+47.92% 14.09B
Average -0.36%+1.05%+72.11%+97.90% 27.96B
Weighted average by Cap. -0.55%+1.15%+105.40%+141.23%

Financials

2026 *2027 *
Net sales 600M 699M 562M 514M 968M 66.78B 971M 6.65B 2.6B 33.44B 2.62B 2.57B 111B 719M 838M 674M 616M 1.16B 80.09B 1.16B 7.97B 3.12B 40.1B 3.15B 3.08B 134B
Net income -236M -275M -221M -202M -381M -26.26B -382M -2.61B -1.02B -13.15B -1.03B -1.01B -43.79B -60.37M -70.35M -56.56M -51.74M -97.45M -6.72B -97.79M -669M -262M -3.37B -264M -258M -11.21B
Net Debt 143M 166M 134M 122M 231M 15.91B 231M 1.58B 619M 7.96B 625M 611M 26.53B 162M 189M 152M 139M 262M 18.06B 263M 1.8B 703M 9.04B 709M 694M 30.11B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
27/08/26 €3.384 +0.89% 301,999
26/08/26 €3.354 +3.07% 930,144
25/08/26 €3.254 -0.61% 1,089,610
24/08/26 €3.274 -2.44% 599,723
21/08/26 €3.356 0.00% 312,228
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.384EUR
Average target price
4.586EUR
Spread / Average Target
+35.51%

Quarterly revenue - Rate of surprise